Revealed! Floyd Mayweather received banned IVs day before Manny Pacquiao fight
Published 10/09/2015 | 08:15
Floyd Mayweather Jr received banned intravenous vitamin injections the day before his May 2 megafight against Manny Pacquiao which failed to comply with World Anti-Doping Agency guidelines, it was disclosed late Wednesday in the USA.
The U.S. Anti-Doping Agency did not then issue a therapeutic use exception to Mayweather for the IVs until almost three weeks after the contest.
The report on SB Nation into drug testing in boxing, written by Thomas Hauser, revealed that Mayweather was discovered by the U.S. Anti-Doping Agency to have received an intravenous vitamin injection the day before his May fight against Pacquiao, when employees of USADA had arrived to give Mayweather a random drug test at his home after the fight’s weigh-in on Friday May 1.
The officials “found evidence of an IV being administered” to the boxer at the time. Nevada State Athletic Commission executive director Bob Bennett confirmed in the report that USADA did not declare to the NSAC that Mayweather was receiving an injection.
According to Mayweather’s medical team, the fighter was given two different vitamin mixes -saline and vitamins- both of which were to treat dehydration. While the injections themselves did not include any banned substances, and Mayweather has never tested for any banned substance in his 19-year professional career, IVs are banned under WADA guidelines because they can be used to “dilute or mask the presence of another substance,” Hauser's report disclosed.
To compound the disclosure, Mayweather was then granted a retrospective therapeutic use exemption (TUE) to receive the IV injections by USADA. Yet Mayweather's team had not applied for the TUE until 18 days after the fight against Pacquiao, 19 days after his test, according to Hauser's report. May weather went on to defeat Pacquiao by unanimous decision.
USADA chose not to notify the NSAC about the procedure until May 21, when USADA sent a letter to Bob Bennett, the NSAC director and NSAC chairman Francisco Aguilar, with a copy to Top Rank (Pacquiao's promoter), informing them that a retrospective therapeutic use exemption (TUE) had been granted.
Bennett told the Las Vegas Review-Journal on Wednesday that while he has no issue with Mayweather, who has always been an anti-doping advocate, he now has concerns over the actions of USADA officials, who should, he believes, have declared it immediately to the regulatory NSAC body, which is a state government agency.
"Floyd has always been a proponent of drug testing, which I applaud," Bennett told the Las Vegas Review-Journal. "He's set a fine example for all to emulate. He's never tested positive in his entire career for any performance-enhancing drugs and, as a commission, we have no problem with Floyd Mayweather."
"As far as USADA, I was extremely disappointed that I wasn't notified right away. When it comes to TUE, we are the sole agency that approves the administering of TUEs. USADA, nor any other anti-doping agency that does drug testing, doesn't have the authority to adminster a TUE."
"The bottom line is USADA didn't keep us informed, which is totally unacceptable and unprofessional." The disclosure is likely to lead to an inquiry buy NSAC into the dealings of the USADA, over its lack of transparency, and its relationships with individuals being tested.
Pacquiao received a visit from a United States Anti-Doping Agency (USADA) representative shortly before taking to the scale on May 1, the thirteenth time he was asked to submit a urine or blood sample to the performance enhancing drug testing company in the build-up to the superfight.